https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Fertility Rate, Total for the United States (SPDYNTFRTINUSA) from 1960 to 2023 about fertility, rate, and USA.
The fertility rate of a country is the average number of children that women from that country will have throughout their reproductive years. In the United States in 1800, the average woman of childbearing age would have seven children over the course of their lifetime. As factors such as technology, hygiene, medicine and education improved, women were having fewer children than before, reaching just two children per woman in 1940. This changed quite dramatically in the aftermath of the Second World War, rising sharply to over 3.5 children per woman in 1960 (children born between 1946 and 1964 are nowadays known as the 'Baby Boomer' generation, and they make up roughly twenty percent of todays US population). Due to the end of the baby boom and increased access to contraception, fertility reached it's lowest point in the US in 1980, where it was just 1.77. It did however rise to over two children per woman between 1995 and 2010, although it is expected to drop again by 2020, to just 1.78.
Native Hawaiian and Pacific Islander women had the highest fertility rate of any ethnicity in the United States in 2022, with about 2,237.5 births per 1,000 women. The fertility rate for all ethnicities in the U.S. was 1,656.5 births per 1,000 women. What is the total fertility rate? The total fertility rate is an estimation of the number of children who would theoretically be born per 1,000 women through their childbearing years (generally considered to be between the ages of 15 and 44) according to age-specific fertility rates. The fertility rate is different from the birth rate, in that the birth rate is the number of births in relation to the population over a specific period of time. Fertility rates around the world Fertility rates around the world differ on a country-by-country basis, and more industrialized countries tend to see lower fertility rates. For example, Niger topped the list of the countries with the highest fertility rates, and Taiwan had the lowest fertility rate.
The total fertility rate of the world has dropped from around 5 children per woman in 1950, to 2.2 children per woman in 2025, which means that women today are having fewer than half the number of children that women did 75 years ago. Replacement level fertility This change has come as a result of the global demographic transition, and is influenced by factors such as the significant reduction in infant and child mortality, reduced number of child marriages, increased educational and vocational opportunities for women, and the increased efficacy and availability of contraception. While this change has become synonymous with societal progress, it does have wide-reaching demographic impact - if the global average falls below replacement level (roughly 2.1 children per woman), as is expected to happen in the 2050s, then this will lead to long-term population decline on a global scale. Regional variations When broken down by continent, Africa is the only region with a fertility rate above the global average, and, alongside Oceania, it is the only region with a fertility rate above replacement level. Until the 1980s, the average woman in Africa could expect to have 6-7 children over the course of their lifetime, and there are still several countries in Africa where women can still expect to have 5 or more children in 2025. Historically, Europe has had the lowest fertility rates in the world over the past century, falling below replacement level in 1975. Europe's population has grown through a combination of migration and increasing life expectancy, however even high immigration rates could not prevent its population from going into decline in 2021.
While the standard image of the nuclear family with two parents and 2.5 children has persisted in the American imagination, the number of births in the U.S. has steadily been decreasing since 1990, with about 3.6 million babies born in 2023. In 1990, this figure was 4.16 million. Birth and replacement rates A country’s birth rate is defined as the number of live births per 1,000 inhabitants, and it is this particularly important number that has been decreasing over the past few decades. The declining birth rate is not solely an American problem, with EU member states showing comparable rates to the U.S. Additionally, each country has what is called a “replacement rate.” The replacement rate is the rate of fertility needed to keep a population stable when compared with the death rate. In the U.S., the fertility rate needed to keep the population stable is around 2.1 children per woman, but this figure was at 1.67 in 2022. Falling birth rates Currently, there is much discussion as to what exactly is causing the birth rate to decrease in the United States. There seem to be several factors in play, including longer life expectancies, financial concerns (such as the economic crisis of 2008), and an increased focus on careers, all of which are causing people to wait longer to start a family. How international governments will handle falling populations remains to be seen, but what is clear is that the declining birth rate is a multifaceted problem without an easy solution.
The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The average for 2022 based on 195 countries was 18.38 births per 1000 people. The highest value was in Niger: 45.03 births per 1000 people and the lowest value was in Hong Kong: 4.4 births per 1000 people. The indicator is available from 1960 to 2022. Below is a chart for all countries where data are available.
In 2023, around 50 children were born per thousand Asian women in the United States. The highest birth rate was among Native Hawaiian and other Pacific Islander mothers, at 79 percent during the same year.
In 2019, Hispanic women with no high school diploma or no college degree had higher total fertility rates (TFR) compared to women of other ethnicities. This difference changed with educational level and among women with a doctorate or professional degree, there was almost no difference in TFR between Hispanic and non-Hispanic white women. This statistic depicts the total fertility rate of U.S. women in 2019, by maternal educational attainment and ethnicity.
In 2023, women in households with an income below the poverty threshold had the highest birth rate in the United States, at 72 births per 1,000 women.
Today, globally, women of childbearing age have an average of approximately 2.2 children over the course of their lifetime. In pre-industrial times, most women could expect to have somewhere between five and ten live births throughout their lifetime; however, the demographic transition then sees fertility rates fall significantly. Looking ahead, it is believed that the global fertility rate will fall below replacement level in the 2050s, which will eventually lead to population decline when life expectancy plateaus. Recent decades Between the 1950s and 1970s, the global fertility rate was roughly five children per woman - this was partly due to the post-WWII baby boom in many countries, on top of already-high rates in less-developed countries. The drop around 1960 can be attributed to China's "Great Leap Forward", where famine and disease in the world's most populous country saw the global fertility rate drop by roughly 0.5 children per woman. Between the 1970s and today, fertility rates fell consistently, although the rate of decline noticeably slowed as the baby boomer generation then began having their own children. Replacement level fertility Replacement level fertility, i.e. the number of children born per woman that a population needs for long-term stability, is approximately 2.1 children per woman. Populations may continue to grow naturally despite below-replacement level fertility, due to reduced mortality and increased life expectancy, however, these will plateau with time and then population decline will occur. It is believed that the global fertility rate will drop below replacement level in the mid-2050s, although improvements in healthcare and living standards will see population growth continue into the 2080s when the global population will then start falling.
In 2021, the birth rate in the United States was highest in families that had under 10,000 U.S. dollars in income per year, at 62.75 births per 1,000 women. As the income scale increases, the birth rate decreases, with families making 200,000 U.S. dollars or more per year having the second-lowest birth rate, at 47.57 births per 1,000 women. Income and the birth rate Income and high birth rates are strongly linked, not just in the United States, but around the world. Women in lower income brackets tend to have higher birth rates across the board. There are many factors at play in birth rates, such as the education level of the mother, ethnicity of the mother, and even where someone lives. The fertility rate in the United States The fertility rate in the United States has declined in recent years, and it seems that more and more women are waiting longer to begin having children. Studies have shown that the average age of the mother at the birth of their first child in the United States was 27.4 years old, although this figure varies for different ethnic origins.
In 2025, there are six countries, all in Sub-Saharan Africa, where the average woman of childbearing age can expect to have between 5-6 children throughout their lifetime. In fact, of the 20 countries in the world with the highest fertility rates, Afghanistan and Yemen are the only countries not found in Sub-Saharan Africa. High fertility rates in Africa With a fertility rate of almost six children per woman, Chad is the country with the highest fertility rate in the world. Population growth in Chad is among the highest in the world. Lack of healthcare access, as well as food instability, political instability, and climate change, are all exacerbating conditions that keep Chad's infant mortality rates high, which is generally the driver behind high fertility rates. This situation is common across much of the continent, and, although there has been considerable progress in recent decades, development in Sub-Saharan Africa is not moving as quickly as it did in other regions. Demographic transition While these countries have the highest fertility rates in the world, their rates are all on a generally downward trajectory due to a phenomenon known as the demographic transition. The third stage (of five) of this transition sees birth rates drop in response to decreased infant and child mortality, as families no longer feel the need to compensate for lost children. Eventually, fertility rates fall below replacement level (approximately 2.1 children per woman), which eventually leads to natural population decline once life expectancy plateaus. In some of the most developed countries today, low fertility rates are creating severe econoic and societal challenges as workforces are shrinking while aging populations are placin a greater burden on both public and personal resources.
From now until 2100, India and China will remain the most populous countries in the world, however China's population decline has already started, and it is on course to fall by around 50 percent in the 2090s; while India's population decline is projected to begin in the 2060s. Of the 10 most populous countries in the world in 2100, five will be located in Asia, four in Africa, as well as the United States. Rapid growth in Africa Rapid population growth across Africa will see the continent's population grow from around 1.5 billion people in 2024 to 3.8 billion in 2100. Additionally, unlike China or India, population growth in many of these countries is not expected to go into decline, and instead is expected to continue well into the 2100s. Previous estimates had projected these countries' populations would be much higher by 2100 (the 2019 report estimated Nigeria's population would exceed 650 million), yet the increased threat of the climate crisis and persistent instability is delaying demographic development and extending population growth. The U.S. as an outlier Compared to the nine other largest populations in 2100, the United States stands out as it is more demographically advanced, politically stable, and economically stronger. However, while most other so-called "advanced countries" are projected to see their population decline drastically in the coming decades, the U.S. population is projected to continue growing into the 2100s. This will largely be driven by high rates of immigration into the U.S., which will drive growth despite fertility rates being around 1.6 births per woman (below the replacement level of 2.1 births per woman), and the slowing rate of life expectancy. Current projections estimate the U.S. will have a net migration rate over 1.2 million people per year for the remainder of the century.
https://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
The global assistive reproductive technology (ART) market, valued at $28.96 billion in 2025, is projected to experience robust growth, with a compound annual growth rate (CAGR) of 4.4% from 2025 to 2033. This expansion is fueled by several key factors. Rising infertility rates globally, driven by delayed pregnancies, lifestyle choices, and increasing prevalence of sexually transmitted infections, are significantly contributing to market growth. Technological advancements in ART procedures, including improved IVF techniques, the development of less invasive procedures like AI-IUI, and enhanced embryo selection methods, are also driving demand. The increasing availability of fertility treatments in both private and public healthcare settings, coupled with rising awareness and acceptance of ART, further contributes to market expansion. Furthermore, the growing geriatric population seeking reproductive options and the increasing accessibility of financing options for ART treatments are adding to the market's upward trajectory. Regional variations exist, with North America and Europe currently holding the largest market shares, although developing regions in Asia-Pacific are anticipated to witness significant growth in the coming years due to expanding populations and increased healthcare investments. The ART market segmentation reveals a substantial share held by In-vitro fertilization (IVF), followed by Artificial Insemination-Intrauterine Insemination (AI-IUI) and Frozen Embryo Replacement (FER). Fertility clinics and IVF centers constitute the largest application segments, showcasing the crucial role of specialized facilities in the ART landscape. Major players such as Cooper Surgical, Hamilton Thorne, and FUJIFILM Irvine Scientific are shaping the market through technological innovations and strategic expansions. The market faces certain restraints, including high treatment costs, ethical considerations surrounding ART, and regulatory hurdles in some regions. However, ongoing research, development of more effective and affordable ART techniques, and increasing government support are likely to mitigate these challenges and sustain the market's positive trajectory.
https://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The global assistive reproductive technology (ART) market is experiencing robust growth, driven by increasing infertility rates worldwide, advancements in ART techniques, and rising awareness about fertility treatments. The market, currently valued at approximately $20 billion in 2025, is projected to witness a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching an estimated market value of $35 billion by 2033. This growth is fueled by factors such as the increasing prevalence of lifestyle diseases impacting fertility, delayed childbearing among women, and the expanding availability of advanced technologies like IVF and IUI across a broader range of healthcare settings, including specialized fertility clinics and general hospitals. Technological innovations, including improvements in embryo selection and genetic screening, are further enhancing success rates and driving market expansion. The segment dominated by In-vitro fertilization (IVF) procedures, due to its relatively higher success rates compared to other ART methods. Geographically, North America and Europe currently hold significant market share, attributed to high disposable incomes, well-established healthcare infrastructure, and increased awareness regarding ART options. However, the Asia-Pacific region is expected to demonstrate substantial growth during the forecast period, driven by increasing population, rising healthcare expenditure, and expanding access to ART services. Despite the positive growth trajectory, the ART market faces certain restraints. High treatment costs, stringent regulatory frameworks surrounding ART procedures, and ethical considerations associated with advanced reproductive technologies pose challenges to market penetration. Furthermore, variations in reimbursement policies across different regions and insurance coverage limits can restrict patient access to these life-changing treatments. Nevertheless, the overall market outlook remains optimistic, driven by continuous technological advancements, growing awareness, and increasing governmental support for expanding access to ART services. The competitive landscape is characterized by a mix of established players like CooperSurgical, Merck, and Vitrolife, alongside emerging companies focusing on innovative ART technologies. This dynamic environment is set to drive further innovation and competition, ultimately benefiting patients seeking reproductive assistance.
https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
The durable baby goods stores industry faces significant challenges tied to historic low birth rates and shifting demographics. Data from the CDC reveals that in 2024, the US recorded 3,622,673 births, representing only a 1.0% climb from the previous year, with the fertility rate at 1.62 births per woman, significantly below the replacement level of 2.1. This has resulted in limited demand growth for big-ticket baby items, placing retailers under pressure to achieve sales growth. Changing family structures and preferences are diversifying and fragmenting the consumer base, adding unpredictability to demand. Through the five years to 2025, industry revenue has gained at a CAGR of 0.6% to $15.6 billion in 2025, including a 0.6% gain in 2025 alone. Retailers are pivoting to cope with these challenges. Differentiating their offerings through enhancing safety, sustainability and smart technology features is a popular tactic. Retailers have taken measures such as expanding their baby and toddler segment with more affordable products, improving their baby registry program and offering exclusive deals. Simultaneously, product innovation is reshaping the industry with a surge in demand for eco-friendly materials, smart technology integration and customizable solutions. The expansion of e-commerce has also heightened industry competition, forcing many retailers to invest significantly in seamless online experiences and personalized marketing strategies. Heightened competition has caused profit to stagnate, reaching 4.1% in 2025. The fertility rate is projected to continue its gradual drop, making strategic innovation and brand loyalty cultivation even more crucial for retailers. Social media will emerge as a potent influence, shaping industry trends and consumer preferences whilst creating direct engagement opportunities for brands. As such, a more integrated use of social media in brand strategy will be vital. With growing household incomes and a more discerning consumer base, premiumization will become a more prominent trend in the industry, primarily focusing on safety, sustainability and superior quality. Simultaneously, as consumer preference for online shopping grows, online sales of baby products are expected to surge, creating opportunities and competition for established and direct-to-consumer brands. Industry revenue will climb at an estimated CAGR of 1.7% to $17.0 billion in 2030.
https://www.marketresearchforecast.com/privacy-policyhttps://www.marketresearchforecast.com/privacy-policy
The global Buserelin market is experiencing robust growth, driven by increasing prevalence of reproductive disorders and the rising demand for effective fertility treatments. The market is segmented by purity level (less than 98%, 98-99%, and more than 99%) and application (research and medical). While precise market sizing data is unavailable, we can reasonably estimate the 2025 market value based on industry trends and competitor activity. Considering the presence of numerous established players like Cayman Chemical and Key Organics, along with emerging companies such as Alfa Chemistry and Clearsynth, the market is likely competitive, suggesting a significant total addressable market (TAM). The medical application segment dominates due to Buserelin's crucial role in assisted reproductive technologies (ART) and hormone replacement therapies. The high-purity segment (more than 99%) commands a premium price, reflecting the stringent quality requirements of medical applications. Growth is further fueled by ongoing research into new applications and improved formulations of Buserelin, along with a growing awareness and acceptance of fertility treatments worldwide. Geographic distribution likely shows a strong presence in North America and Europe, given the advanced healthcare infrastructure and higher adoption rates of ART. However, emerging markets in Asia-Pacific, particularly India and China, are poised for significant growth due to increasing healthcare spending and expanding access to fertility clinics. The restraints on market growth might include the high cost of Buserelin treatments, strict regulatory approvals needed for new applications, and potential side effects associated with its use. Nevertheless, advancements in manufacturing processes and the development of more targeted and efficient formulations are mitigating these challenges. The forecast period (2025-2033) indicates continued expansion, propelled by an expected CAGR reflecting the steady increase in demand and the ongoing investments in research and development within this sector. This positive outlook positions Buserelin as a key component within the broader reproductive healthcare market, presenting attractive opportunities for companies involved in its production and distribution. Competitive landscape analysis would reveal market share distribution among various players, indicating the presence of both large multinational corporations and smaller niche players catering to specific market segments.
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the Cradles Market Size is USD XX million in 2024 and is set to achieve a market size of USD XX million by the end of 2033, growing at a CAGR of XX% from 2024 to 2033. North America dominated the market and held a share of XX% in the year 2024 Europe held a share of XX% in the year 2024 Asia-Pacific was the fastest growing segment and held a share of XX% in the year 2024 South America held a share of XX% in the year 2024 Middle East and Africa held a share of XX% in the year 2024 Market Dynamics of the Cradles Market
Driver of the Cradles Market
Growing awareness of safe sleep practices is driving the demand for the Cradle Market
Increasing awareness of safe sleep practices, such as the American Academy of Pediatrics recommendations for infant sleep safety, drives the demand for cradles that meet these standards. As parents become increasingly informed about the importance of safe sleep environments, they are seeking cradles that meet these standards and provide comfort spacing for their babies. This trend is fueled by recommendations from reputed organizations such as the American Academy of Pediatrics, which emphasizes the importance of safe sleep to reduce risks of SIDS and other sleep-related risks. Diagniologists advise families to reduce the risk of sleep-related infant death by placing infants on their backs in their own sleep space, using a crib, bassinet, or play yard with a firm mattress and fitted sheet, avoiding sleep on a couch or armchair, keeping loose blankets, pillows, stuffed toys, bumpers, and other soft items out of the sleep space, breastfeeding if possible, and avoiding smoking. As a result, parents are actively seeking out cradles that are designed with safety and health in mind. They want products that exceed safety standards, like sturdy construction, secure fastening systems, and breathable material. The demand for safe and healthy sleep is also driven by the growing awareness of the importance of sleep for infant development. Research has shown that sleep plays a beneficial role in brain development, physical growth, and emotional well-being. The early years of life are characterized by dramatic developmental changes. Within this important period lies the transition from newborn to childhood. Sleep is one of the primary activities of the brain during early development and plays an important role in healthy cognitive and psychosocial development in early life. The demand for cradles that prioritize safety, comfort, and healthy sleep habits is driven by factors like growing awareness of safe sleep habits and rising parental concerns about infant health and well-being. Restraint of the Cradles Market
The demand for the cradles market is restrained by declining birth rates in many countries and the increasing popularity of alternative sleeping options.
The demand for cradles is restrained by declining birth rates in many countries, particularly in developed economies. This demographic trend reduces the potential market size for cradles, making it challenging for manufacturers to maintain their sales. The global TFR has more than halved over the past 70 years, from around five children for each female in 1950 to 2.2 children in 2021—with over half of all countries and territories (110 of 204) below the population replacement level of 2.1 births per female as of 2021. This trend is particularly worrying for places such as South Korea and Serbia, where the rate is less than 1.1 children for each female. Another restraint is the increasing popularity of alternative sleeping options for infants, such as co-sleeping, bed-sharing, or using playards and bassinets. These alternatives may appeal to parents who value convenience, flexibility, or cultural traditions, potentially reducing demand for traditional cradles. The trend towards minimalism and simplicity in parenting may also contribute to reduced demand for cradles. Some parents opt for more basic, space-saving sleeping solutions rather than investing in cradles, which are expensive and occupy space. These restraints underscore the need to innovate and adapt to consumer preferences and target niche markets to maintain demand and drive growth. Introduction to the Cradles Market.
The cradle market is a rapidly evolving industry that prioritizes child safety and comfort. This is a traditional market that provides sleeping solutions for infants. Cradle...
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 48.63(USD Billion) |
MARKET SIZE 2024 | 51.69(USD Billion) |
MARKET SIZE 2032 | 84.2(USD Billion) |
SEGMENTS COVERED | Product Type ,Application ,Distribution Channel ,End User ,Age Group ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Rising incidence of womens health conditions Increasing awareness of womens health issues Growing demand for personalized medicine Technological advancements Expanding access to healthcare |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Eli Lilly ,Johnson & Johnson ,GlaxoSmithKline ,AstraZeneca. ,Sanofi. ,Gilead Sciences. ,Bayer ,Merck & Co ,Novartis ,Pfizer ,Roche. ,Teva Pharmaceutical Industries ,Amgen. ,BristolMyers Squibb ,AbbVie. |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Fertility treatments Contraceptive innovations Menopause therapies Breast cancer treatments Prenatal care advancements |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.29% (2025 - 2032) |
https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Fertility Rate, Total for the United States (SPDYNTFRTINUSA) from 1960 to 2023 about fertility, rate, and USA.